Literature DB >> 23255024

Peripheral neuropathy electrophysiological screening in inflammatory bowel disease.

Asimenia Babali1, Aikaterini Terzoudi, Konstantinos Vadikolias, Vasileios Souftas, Konstantinos Kleitsas, Michail Pitiakoudis, Haritomeni Piperidou, Nikolaos Lirantzopoulos, Georgios Kouklakis.   

Abstract

AIM: Peripheral neuropathy is often described in inflammatory bowel disease (IBD). The aim of this study was to assess the need for neurophysiological testing in IBD patients without neurological symptoms or signs to detect early subclinical neuropathy and its possible correlations with clinical and demographic characteristics.
MATERIALS AND METHODS: Ninety-seven consecutive IBD patients were screened for neurological symptoms and clinical signs, and those without symptoms or signs were included. Also, patients with comorbidities associated with peripheral neuropathy or a history of neurological disease were excluded. The remaining 45 asymptomatic patients were tested electrophysiologically for peripheral nerve involvement.
RESULTS: None of the examined patients showed evidence for subclinical neuropathy.
CONCLUSION: IBD patients with a normal neurological clinical examination and no symptoms have no evidence for neuropathy. Therefore, proper electrophysiological testing is not considered necessary.

Entities:  

Mesh:

Year:  2013        PMID: 23255024     DOI: 10.1097/MEG.0b013e32835ceca6

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

Review 1.  Inflammatory bowel disease: an increased risk factor for neurologic complications.

Authors:  Germán Morís
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

2.  Neurological manifestations related to Crohn's disease: a boon for the workforce.

Authors:  Reza Nemati; Somayeh Mehdizadeh; Hooman Salimipour; Ehsan Yaghoubi; Zeinab Alipour; Seyed Masoud Tabib; Majid Assadi
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.